Drug Profile
Research programme: enterovirus A monoclonal antibodies - A*STAR/Cytos Biotechnology
Latest Information Update: 18 Aug 2011
Price :
$50
*
At a glance
- Originator Agency for Science, Technology and Research; Cytos Biotechnology
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Enterovirus infections
Most Recent Events
- 18 Aug 2011 No development reported for Enterovirus infections in Singapore (Parenteral)
- 03 Apr 2009 Early research in Enterovirus infections in Singapore (Parenteral)